NL-OMON31451CompletedNot Applicable
High dose adenosine in acute myocardial infarction study - Hammer 2
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Medisch Spectrum Twente
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Patients with acute myocardial infarction with clinical indication for primary PCI.
- •Symptoms of myocardial ischemia less then 6 hours (12 hours in case of anterior infarction with persistent complaints).
Exclusion Criteria
- •history of myocardial infarction
- •history of heart surgery
- •obstructive lungdisease
- •second degree AV-block.
- •pregnant women
- •contra-indication for MRI
- •impossibility to give informed consent
Investigators
Similar Trials
Not yet recruiting
Not Applicable
High dose adenosine in acute myocardial infarction studyPatients with acute myocardial infarction treated by primary PCINL-OMON23567none80
Completed
Not Applicable
ow-dose Adenosine-Induced Cardiac Arrest during intracranial aneurysm surgery: A single-center experienceSubarachnoid hemorrhageoneAdenosineCerebral aneurysmInduced cardiac arrestLow-doseSurgeryTCTR20191212001Goverment8
Active, not recruiting
Phase 1
Adenosine as an adjunct to standaard blood cardioplegiaPost-operative cardiac damage in patients scheduled for minimal invasive, port-access operationsEUCTR2015-001923-22-NLAmphia Ziekenhuis100
Active, not recruiting
Phase 1
Adenosiinilla aloitettu kardioplegia sydämen suojanaEUCTR2014-001382-26-FITAYS Sydänsairaala80
Unknown
Not Applicable
Hyperemic Efficacy of IV Adenosine in HFrEFHeart Failure With Reduced Ejection FractionCoronary Artery DiseaseNCT03235700Sejong General Hospital125